The Medicare experiment to promote more vigorous and effective use of medication therapy management in stand-alone Part D prescription drug plans has led to significant savings in medical expenses after one year, the US Centers for Medicare and Medicaid Services reports.
In 2017, participants in the Enhanced MTM Model spent approximately $325m less than the anticipated spending benchmark across the 1.7m...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?